NLSP (NLS Pharmaceutics Ltd.) Net earnings per share (EPS TTM)

NLS Pharma (NLSP) - corporate logo

NLS Pharmaceutics AG focuses on sleep disorder therapies utilizing a network of specialized centers. The trailing twelve-month EPS dynamics on GURU.Markets reflect this trajectory, where the 52.20 metric indicates the current value. The company's prospects rely on the regulation of circadian rhythms, while final risks depend on clinical test results and regulatory approval timelines.

NLS Pharma - NLSP Earnings per share for the last twelve months (period 02/11/2024 - 02/20/2024)

NLSP (NLS Pharma): analytical breakdowns and indicator data

Fundamental company valuation:NLSP NLS Pharmaceutics AG
Flagship merchandise of NLS Pharmaceutics Ltd.

The market evaluates NLS Pharmaceutics AG (NLSP) through the lens of capital management efficiency within a high-risk sector. This indicator measures the dynamics of earnings per share over a rolling year, comparing current results with historical data. By analyzing the annual EPS TTM growth measurement, an investor sees the value 52.20, which reflects the business monetization rates. The growth of this metric confirms the profitability of the strict logistics for narcolepsy treatments. The stability of this trend guarantees the resilience of the company's fundamental value.

Direct competitors

Net earnings per one share for the last twelve months Jazz Pharma|CYTK (Cytokinetics Inc.) - Net earnings per share for the last 12 months|PTC Bio (PTCT) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Scholar Rock|CNTA: Earnings per share for the trailing year|Earnings per share for the last twelve months Dyne Therapeutics (DYN)|EWTX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Rapport Pharma RAPP|Alumis Pharma - Earnings per share for the last twelve months|ZVRA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Contineum Therapeutics, Inc.|LRMR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Capricor Therapeutics CAPR|Net earnings per share for the last 12 months TRDA|Net earnings per one share for the last twelve months Channel PTHS|Earnings per share for the last twelve months MediciNova Inc. (MNOV)|SER - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BTAI (BioXcel Therapeutics Inc)|ProMIS Neurosciences (PMN) - Net earnings per one share for the last twelve months|Apimeds Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AEON Biopharma, Inc.|Bionomics Limited (BNOX) - Earnings per share for the last twelve months|fsdpharma.com - Earnings per share for the trailing year|RETA (reatapharma.com) - Net earnings per share (EPS TTM)